19966906|t|Current and emerging treatments for amyotrophic lateral sclerosis.
19966906|a|BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a relatively rare neurodegenerative disorder of both upper and lower motoneurons. Currently, the management of ALS is essentially symptoms-based, and riluzole, an antiglutamatergic agent, is the only drug for the treatment of ALS approved by the food and drug administration. OBJECTIVE: We reviewed current literature concerning emerging treatments for amyotrophic lateral sclerosis. METHODS: A Medline literature search was performed to identify all studies on ALS treatment published from January 1st, 1986 through August 31st, 2009. We selected papers concerning only disease-modifying therapy. RESULTS: Forty-eight compounds were identified and reviewed in this study. CONCLUSIONS: Riluzole is the only compound that demonstrated a beneficial effect on ALS patients, but with only modest increase in survival. Although several drugs showed effective results in the animal models for ALS, none of them significantly prolonged survival or improved quality of life of ALS patients. Several factors have been implicated in explaining the predominantly negative results of numerous randomized clinical trials in ALS, including methodological problems in the use of animal-drug screening, the lack of assessment of pharmacokinetic profile of the drugs, and methodological pitfalls of clinical trials in ALS patients.
19966906	36	65	amyotrophic lateral sclerosis	Disease	MESH:D000690
19966906	79	108	Amyotrophic lateral sclerosis	Disease	MESH:D000690
19966906	110	113	ALS	Disease	MESH:D000690
19966906	136	162	neurodegenerative disorder	Disease	MESH:D019636
19966906	229	232	ALS	Disease	MESH:D000690
19966906	268	276	riluzole	Chemical	MESH:D019782
19966906	344	347	ALS	Disease	MESH:D000690
19966906	471	500	amyotrophic lateral sclerosis	Disease	MESH:D000690
19966906	580	583	ALS	Disease	MESH:D000690
19966906	804	812	Riluzole	Chemical	MESH:D019782
19966906	875	878	ALS	Disease	MESH:D000690
19966906	879	887	patients	Species	9606
19966906	1005	1008	ALS	Disease	MESH:D000690
19966906	1087	1090	ALS	Disease	MESH:D000690
19966906	1091	1099	patients	Species	9606
19966906	1229	1232	ALS	Disease	MESH:D000690
19966906	1419	1422	ALS	Disease	MESH:D000690
19966906	1423	1431	patients	Species	9606
19966906	Negative_Correlation	MESH:D019782	MESH:D000690

